Session Information
2008 Midyear Clinical Meeting
Click here to go to the previous page
Multitasking: Expanded Use of Antineoplastic Agents to Treat Autoimmune and Inflammatory Disorders
Track:
Educational Sessions
Program Code: 264-L01
Date: Wednesday, December 10, 2008
Time: 2:00 PM to 4:00 PM EST
Location:
S230C
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Lois Parker, BS, RPh, Senior Attending Pharmacist and Continuing Education Administrator, Massachusetts General Hospital
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Regina Holdstock, RPh, BCOP, Oncology Pharmacy Manager Massachusetts General Hospital, Massachusetts General Hospital Lois Parker, BS, RPh, Senior Attending Pharmacist and Continuing Education Administrator, Massachusetts General Hospital- Describe the goals of treatment when using antineoplastic agents to treat non-oncologic conditions.
- Discuss the role that newer agents, such as biologic response modifiers, may play in the management of autoimmune and inflammatory conditions.
- Identify some of the challenges health-system pharmacists face in managing and handling these agents and discuss possible solutions.
- List several antineoplastic agents that are also used in autoimmune and inflammatory disorders.